Editorial
Published on 13 Jul 2023
Editorial: Assessment and management of adverse drug reactions in oncology
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1223078
- 1,591 views
Type at least 3 characters
53 articles
Articles
Original Research
Published on 04 Jul 2023
Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1126012
- 2,169 views
- 2 citations
Editorial
Published on 24 May 2023
Editorial: Immune-related adverse Events (irAEs) of biopharmaceuticals
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1214914
- 1,153 views
Editorial
Published on 11 May 2023
Editorial: Diagnosis and management of allergy to chemotherapy and biologics
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1205345
- 1,997 views
- 2 citations
Case Report
Published on 09 May 2023
Case report: Insulin desensitization as the only option for managing insulin allergy in a Sudanese patient
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1089966
- 1,979 views
- 1 citation
Brief Research Report
Published on 03 May 2023
Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1056619
- 1,850 views
- 1 citation
Brief Research Report
Published on 30 Mar 2023
A potential cost savings analysis of a penicillin de-labeling program
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1101321
- 1,817 views
- 4 citations
Mini Review
Published on 16 Mar 2023
Delabelling multiple antibiotic allergy: Practical issues
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1156137
- 4,064 views
- 3 citations
Mini Review
Published on 02 Mar 2023
Mucocutaneous adverse events to immune checkpoint inhibitors
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1147513
- 4,137 views
- 4 citations
Original Research
Published on 06 Jan 2023
Cofactors of drug hypersensitivity—A monocenter retrospective analysis
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.1097977
- 1,809 views
- 1 citation
Brief Research Report
Published on 20 Dec 2022
SARS-CoV-2 vaccine excipients polyethylene glycol and trometamol do not induce mast cell degranulation, in an in vitro model for non-IgE-mediated hypersensitivity
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.1046545
- 2,537 views
- 1 citation
Original Research
Published on 05 Dec 2022
Non-steroidal anti-inflammatory drug-induced anaphylaxis infrequent in 388 patients with mastocytosis: A two-center retrospective cohort study
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.1071807
- 3,871 views
- 14 citations
Original Research
Published on 05 Dec 2022
Drug allergy evaluation in children with suspected mild antibiotic allergy
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.1050048
- 2,151 views
- 1 citation
Mini Review
Published on 22 Nov 2022
Differences in beta-lactam and penicillin allergy: Beyond the West and focusing on Asia-Pacific
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.1059321
- 3,385 views
- 16 citations
Original Research
Published on 05 Sep 2022
Hong Kong Drug Allergy Delabelling Initiative (HK-DADI) consensus statements for penicillin allergy testing by nonallergists
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.974138
- 3,553 views
- 9 citations
Brief Research Report
Published on 16 Aug 2022
Prevalence and impact of misdiagnosed drug allergy labels among patients with hereditary angioedema
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.953117
- 2,096 views
- 7 citations